Eric Duckers, MD PhD FESC FACC, is an academic and biopharmaceutical veteran with 35 years of experience in the academia and biotechnology industry. Eric received a B.S. in Pharmacy and Medicine from the University of Utrecht, as a well as a B.S. in Management of Medical Health Care from the University of Rotterdam, a MS/MD in Medicine from the University Utrecht, and a PhD in Neuropharmacology and Molecular Biology from the University of Utrecht (Rudolf Magnus Institute). Eric was offered a chair in Molecular and Cellular Biology of Cardiovascular System as well as Invasive Cardiology at the University of Rotterdam. He has served as the Chief Medical Office and Chief Executive Officer of start‑up companies, including BioTxs, CardioGenx, Okyanos, BioCardia, VST‑Bio and VasoRx.

• 

  Chief Medical Officer in XyloCor Therapeutics

  Gene therapy for advanced coronary artery disease